Diasome Pharmaceuticals, Inc.

New Filing
CIK: 0001411617·Biotechnology·DELAWARE·Filed: Apr 1, 2020
Total Offering

$2,897,788

Amount Sold

$2,885,788

Investors

20

First Sale

Mar 17, 2020

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Robert Geho
Related Person
W. Blair Geho
Related Person
THOMAS MCDONALD
Related Person
Frank McCaney
Related Person
Marc Penn
Related Person

Company

Diasome Pharmaceuticals, Inc.

10000 CEDAR AVENUE

CLEVELAND, OH, 44106

216-444-7110

SEC Filing

0001231919-20-000019

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Diasome Pharmaceuticals, Inc. Form D Filing — $2,897,788 | FilingFlow